Director/PDMR Shareholding

By

Regulatory News | 24 Sep, 2024

RNS Number : 4223F
Halma PLC
24 September 2024
 

Halma plc

Directors' and PDMRs' Share Transactions

 

In accordance with Article 19 of the Market Abuse Regulation, notification is hereby given of transactions in the 10p ordinary shares of Halma by Directors and Persons Discharging Managerial Responsibilities (PDMRs), as set out below.


1

 

Details of the person discharging managerial responsibilities / person closely associated

 

 

a)

 

Name

 

 

Charlene Lim

 

 

2

 

Reason for the notification

 

 

a)

 

Position/status

 

 

Group General Counsel

 

b)

 

Initial notification /Amendment

 

 

Initial notification

 

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

 

a)

 

Name

 

 

Halma plc

 

b)

 

LEI

 

 

2138007FRGLUR9KGBT40

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

 

Ordinary shares of 10p each in Halma plc

 

GB0004052071

 

 

b)

 

Nature of the transaction

 

 

Grant of a Deferred Share Award under the Executive Share Plan

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

 

(1)   Nil

 

16,062

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

 

 

16,062

 

 

Nil

 

 

e)

 

Date of the transaction

 

 

2024-09-23

 

f)

 

Place of the transaction

 

 

Outside a trading venue

 

 

 

 

Contact for further information:

 

 

Mark Jenkins

Company Secretary, Halma plc

Tel:  +44 (0)1494 721111

 

A copy of this announcement, together with other information about Halma, may be viewed on its website:  www.halma.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHVZLBLZKLZBBZ

Last news